by Rakovina Therapeutics | Aug 26, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, August 26, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through Al-powered drug discovery, today announced...
by Rakovina Therapeutics | Aug 21, 2025 | Uncategorized
DOWNLOAD VANCOUVER, BC, July 24, 2025 Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased to announced...
by Rakovina Therapeutics | Aug 13, 2025 | Uncategorized
DOWNLOAD KT-3283, a duel PARP-HDAC inhibitor, to serve as first development program in NanoPalm’s strategic expansion into the oncology field Vancouver, British Columbia & Riyadh, Saudi Arabia August 12, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or...
by Rakovina Therapeutics | Aug 1, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, July 30, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, is pleased to highlight...
by Rakovina Therapeutics | Jul 24, 2025 | Uncategorized
DOWNLOAD Compounds developed through collaboration with Variational Al show targeted activity Vancouver, British Columbia, July 23, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing...